GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
111
c/compounding·posted 1 months ago by u/sigrid_kaufmann

[Lab] SSA survo — Medutest came back 97.4% against a claimed 98.3%

Explainer

Been lurking in c/maintenancephase for about 21 months and finally have something worth posting.

Short version: week 80, 15mg, and API source is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 19 threads, and the answers split roughly down the middle.

What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 86.

165 up / 54 down75% upvoted17 commentsid 1mlnf712 Jun 2026

17 comments

17 in this archive, depth 4

best — the order this archive was captured in

u/tb500_tangent28 points·1 months ago

Every time this gets posted it hits the front page and every time someone has to re-explain it.

replysharereportpermalink
u/hassan_chowdhury21 points·1 months ago·edited

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/lina_ndiaye-11 points·1 months ago

shortage list status is 503B, check the actual list

replysharereportpermalink
u/sigrid_kaufmannOP1 point·1 months ago

state board rules differ, say which state

replysharereportpermalink
u/hydration_hank0 points·1 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/marit_mwangi1 point·1 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/kavya_kravchenko16 points·1 months ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/lukas_vermeulen4 points·1 months ago

Which state? Rules vary.

replysharereportpermalink
[deleted]6 points·1 months ago

[deleted]

replysharereportpermalink
u/mikkel_correia4 points·1 months ago

telehealth costs shortage list plus compounding markup, total varies

replysharereportpermalink
u/sigrid_kaufmannOP0 points·1 months ago

This is correct.

Disagree on that part. 98.3% and 98.4% on the same vial is normal.

replysharereportpermalink
u/marit_laurent0 points·1 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/usp_appendixMOD10 points·1 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/enzo_ferrari3 points·1 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/sigrid_kaufmannOP8 points·1 months ago

Removed a chain here.

Yes, exactly this, and it is the bit that took me 59 weeks to accept.

replysharereportpermalink
u/camila_sandvik9 points·1 months ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
u/elin_ferrari4 points·1 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.